BioHarvest Sciences Inc. Common Stock
NASDAQ:BHSTAgricultural Inputs
+$0.08 today
- Market cap
- $50.25M
- Beta
- 1.33
- P/E (TTM)
- -6.6
- EPS (TTM)
- -$0.50
Volume 0.01M
Average 0.03M
BHST Investing Cash Flow
Net cash used in or generated by investments in assets, acquisitions, and securities.
BioHarvest Sciences Inc. Common StockNASDAQ: BHST
Investing Cash Flow · Q1 FY2026 · quarter ended Mar 2026
Investing cash flow growth accelerates
Q1 FY2026 investing cash flow of $1.59M (cash outflow) rose 134.3% year over year, ahead of the -3.8% change in trailing-twelve-month investing cash flow. Sequentially, it rose 138.5% from the prior quarter. Over 3 fiscal years it compounded at +23.5% a year.
Context
- Investing cash flow amounted to 6.9% of revenue in FY2025, down 5.2 pp from a year earlier.
- Investing cash flow grew in size in 2 of the last 3 fiscal years.
What to watch
Whether quarterly growth of +134.3% holds above the trailing-twelve-month pace of -3.8%.
Sources:Cash FlowText generated from reported figures; not investment advice.
Investing Cash Flow history
USD · from the cash flow
- Latest · FY2025
- (2.37M) USD
- Year-over-year change
- +21.9%
| Period | Period end | Investing Cash Flow | YoY change |
|---|---|---|---|
| FY2025 | 2025-12-31 | (2.37M) | +21.9% |
| FY2024 | 2024-12-31 | (3.03M) | -105.4% |
| FY2023 | 2023-12-31 | (1.47M) | -17.4% |
| FY2022 | 2022-12-31 | (1.26M) | +23.4% |
| FY2021 | 2021-12-31 | (1.64M) | — |
Investing Cash Flow vs competitors
How BHST compares with its peers on the latest reported figures
- BHST's LTM Mar 2026 investing cash flow of $3.3M is the 8th largest of the 9 companies compared; the peer median is $17.73M.
- Its year-over-year change of -3.8% is the lowest of 8, against a peer median of +42.4%.
- Investing cash flow amounts to 9.4% of revenue for BHST, versus a peer median of 8.2%.
| Company | Period | LTM | YoY | 3-year CAGR | % of revenue |
|---|---|---|---|---|---|
| LTM Mar 2026 | $74.29M | +7.1% | -42.4% | 4.0% | |
| LTM Mar 2026 | $52.76M | +1436.3% | -15.7% | 8.2% | |
| LTM Mar 2026 | $51.13M | +7888.9% | — | 66.8% | |
| LTM Mar 2026 | $20.84M | +35.4% | +69.4% | 18.9% | |
| LTM Mar 2026 | $19.28M | +69.1% | +1.3% | 7.1% | |
| LTM May 2025 | $16.18M | +42.4% | +1.2% | 30.7% | |
| LTM Mar 2026 | $4.13M | +18.0% | -37.1% | 0.8% | |
| LTM Mar 2026 | $3.3M | -3.8% | +23.5% | 9.4% | |
USGOU.S. GoldMining Inc. | LTM Feb 2026 | $236.85K | — | — | — |
| Peer median (excluding BHST) | $17.73M | +42.4% | -7.3% | 8.2% | |
Competitors are the stored peer set for BHST. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Cash Flow Statement
Metric | FY2021 Dec 2021 | FY2022 Dec 2022 | FY2023 Dec 2023 | FY2024 Dec 2024 | FY2025 Dec 2025 |
|---|---|---|---|---|---|
| Net Income | (9.83M) | (11.24M) | (12.56M) | (12.91M) | (11.14M) |
| Depreciation & Amortization | 385.58K | 712K | 840K | 1.25M | 1.62M |
| Deferred Income Tax | 0 | 0 | 0 | 0 | 0 |
| Stock-Based Compensation | 3.37M | 1.35M | 563K | 601K | 597K |
| Change in Working Capital | (96K) | (308K) | 755K | (555K) | (1.94M) |
| Accounts Receivables | (266K) | (588K) | (22K) | (594K) | (1.11M) |
| Inventory | (828K) | (450K) | (1.09M) | (1.19M) | (904K) |
| Accounts Payables | 0 | 730K | 0 | 1.04M | 0 |
| Other Working Capital | 998K | 0 | 1.87M | 188K | 67K |
| Other Non-Cash Items | (627K) | 239K | 1.88M | 4.93M | 3.63M |
| Operating Cash Flow | (6.79M) | (9.24M) | (8.52M) | (6.68M) | (7.23M) |
| Capital Expenditures | (1.64M) | (1.26M) | (1.47M) | (2.84M) | (2.36M) |
| Acquisitions (Net) | 0 | 0 | 0 | 0 | 0 |
| Purchases of Investments | 0 | 0 | 0 | 0 | 0 |
| Sales of Investments | 0 | 0 | 0 | 0 | 0 |
| Other Investing Activities | 0 | 0 | 0 | (192K) | (10K) |
| Investing Cash Flow | (1.64M) | (1.26M) | (1.47M) | (3.03M) | (2.37M) |
| Debt Repayment | (332K) | 7.3M | 13.15M | 2.04M | 5.25M |
| Common Stock Issued | 7.47M | 877K | 534.17K | 4.33M | 25.1M |
| Common Stock Repurchased | 0 | 0 | 0 | 0 | 0 |
| Dividends Paid | 0 | 0 | 0 | 0 | 0 |
| Other Financing Activities | 3.64M | (38K) | (131.17K) | 408K | (159K) |
| Financing Cash Flow | 10.77M | 8.14M | 13.56M | 6.78M | 30.19M |
| Effect of Forex Changes | (4K) | (22K) | 59K | (34K) | 39K |
| Net Change in Cash | 2.33M | (2.38M) | 3.62M | (2.97M) | 20.64M |
| Free Cash Flow | (8.43M) | (10.5M) | (10M) | (9.52M) | (9.58M) |
BioHarvest Sciences Inc. Common Stock
NASDAQ:BHST
Intrinsic Alpha fair value
Locked
Current Price
$2.90
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.